NCT Number: NCT00368524
Cost Effective Treatment for Dually Diagnosed Homeless
This randomized controlled trial examined whether an abbreviated treatment using abstinence contingency management for housing and work/training (CM, n=103) with cocaine dependent, non-psychotic, dually diagnosed homeless persons, would show non-inferior outcomes compared to the full treatment (CM+, n=103). It was hypothesized that CM+ would show superior abstinence and retention outcomes, but that CM, with components derived from previously effective behavioral day treatment, would obtain non-inferior outcomes, defined as 75% or more of those observed for the full treatment (CM+) during active treatment months 1-6. The CM+ included all CM components but added behavioral day treatment that included voucher reinforcement of $7.50-15.00, for objective weekly therapeutic goal attainment in five domains of functioning: drug dependence, homelessness, unemployment, non-drug related recreational activities, and behavioral, health, or mental health problems. Abstinence was assessed by observed urine specimen collection and weekly testing weeks 1-52, and randomly, bi-monthly for months 13-18. Abstinence, homelessness, employment and other outcomes were also assessed at baseline, 2, 6, 12, and 18 months.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
McKinney Act criteria for homelessness; DSM IV diagnosis for Cocaine Dependence; self-reported use within the last 2 weeks; psychological distress indicated by score of 70 on 1 or more Brief Symptom Inventory scales; willingness to participate; no plans to move from Birmingham area for 18 months;
-
Exclusion criteria
cognitive impariment precluding informed consent; requiring immediate inpatient medical treatment
Treatment and study plan
Primary outcomes
-
abused drug abstinence measured by observed urine specimen testing weeks 1-52, and bimonthly months 13-18
Secondary outcomes
-
abstinence, housing, employment and other outcomes at 0, 2, 6, 12 and 18 months.
Sponsors and collaborators
Lead sponsor
University of Alabama at Birmingham
Other
Registry information
Important dates
- Study start
- 2001
- Study completion
- 2005
- First posted
- Aug 24, 2006
- Registry last updated
- Mar 27, 2023
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Low-Intensity Focused Ultrasound for Cocaine Use Disorder
NCT05857852
Chemically-Induced Disorders, Cocaine Abuse
Charlottesville, Virginia, United States
View Trial DetailsrTMS for Stimulant Use Disorders
NCT04907357
Chemically-Induced Disorders, Cocaine Abuse
Winston-Salem, North Carolina, United States
View Trial DetailsBupropion-Enhanced Contingency Management (CM) for Cocaine Dependence
NCT02111798
Chemically-Induced Disorders, Cocaine Dependence
Baltimore, Maryland, United States
View Trial DetailsTDCS to Reduce Craving in Cocaine Addiction- Phase 2 Study
NCT04994821
Chemically-Induced Disorders, Cocaine Dependence
New York, United States
View Trial Details